Clinical Outcomes Following a Change in Gestational Diabetes Mellitus Diagnostic Criteria Due to the COVID-19

Niamh Keating1, Kirsten Carpenter2, Kelsey McCarthy2

  • 1UCD Perinatal Research Centre, National Maternity Hospital, University College Dublin, 4 Dublin, Ireland.

Insights

The COVID-19 pandemic led to fewer gestational diabetes mellitus (GDM) diagnoses, but higher-risk pregnancies were still identified. The glucose tolerance test (GTT) remains the gold standard for GDM diagnosis.

Area of Science:

  • Obstetrics and Gynecology
  • Endocrinology
  • Public Health

Background:

  • The COVID-19 pandemic prompted changes in gestational diabetes mellitus (GDM) diagnostic practices in many healthcare centers.
  • Altered diagnostic criteria and testing protocols may have impacted GDM detection rates and management.

Purpose of the Study:

  • To evaluate the impact of COVID-19 related changes on GDM diagnosis and outcomes.
  • To compare GDM detection rates, medication use, and obstetric/fetal outcomes between pre-pandemic and pandemic periods.

Main Methods:

  • A case-control study design was employed.
  • Antenatal patients from April 1 to June 30 in 2019 and 2020 were analyzed.
  • Key metrics included GDM detection rates, medication requirements (insulin, metformin), and birth outcomes.

Main Results:

  • GDM diagnosis rates significantly decreased during the COVID-19 period (20% in 2020 vs. 42.2% in 2019).
  • There was a notable increase in the need for insulin and metformin at diagnosis and term among diagnosed GDM patients in 2020.
  • Despite changes in diagnosis and medication, no significant differences in obstetric or fetal outcomes were observed between the two periods.

Conclusions:

  • The study suggests a potential underdiagnosis of GDM during the COVID-19 pandemic, although high-risk pregnancies were likely still identified.
  • The glucose tolerance test (GTT) is recommended as the gold-standard for GDM diagnosis, with adaptations for social distancing if necessary.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.1K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.5K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
898
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.4K
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
2.1K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
190